These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31799265)

  • 1. Emotional Well-Being Is Impaired in Hidradenitis Suppurativa Patients.
    Senthilnathan A; Kolli SS; Cardwell LA; Richardson IM; Feldman SR; Pichardo RO
    Skin Appendage Disord; 2019 Nov; 5(6):366-369. PubMed ID: 31799265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
    Pavon Blanco A; Turner MA; Petrof G; Weinman J
    Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychosocial burden of hidradenitis suppurativa in Singapore.
    Ooi XT; Choi E; Han H; Ahmad H; Patwardhan KR; Chandran NS
    JAAD Int; 2023 Mar; 10():89-94. PubMed ID: 36691658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the psychological burden of patients with hidradenitis suppurativa.
    Frings VG; Bauer B; Glöditzsch M; Goebeler M; Presser D
    Eur J Dermatol; 2019 Jun; 29(3):294-301. PubMed ID: 31145081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study of Quality of Life and Psychological Aspects in Patients with Psoriasis and Hidradenitis Suppurativa.
    Kouris A; Platsidaki E; Efstathiou V; Katoulis A; Markantoni V; Tsatovidou R; Christodoulou C; Rigopoulos D; Kontochristopoulos G
    Acta Dermatovenerol Croat; 2021 Nov; 29(4):203-210. PubMed ID: 36896691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Hidradenitis Suppurativa Self-Assessment Tool.
    Senthilnathan A; Kolli SS; Cardwell LA; Richardson I; Feldman SR; Pichardo RO
    J Cutan Med Surg; 2019; 23(4):388-390. PubMed ID: 30897946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: an observational study.
    Singh R; Kelly KA; Senthilnathan A; Feldman SR; Pichardo RO
    Arch Dermatol Res; 2023 May; 315(4):1049-1052. PubMed ID: 36315267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa.
    Akoglu G; Yildiz I; Karaismailoğlu E; Esme P
    Dermatol Ther; 2021 May; 34(3):e14910. PubMed ID: 33619860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study.
    Ramos-Alejos-Pita C; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Observational Study to Evaluate the Factors Affecting the Dermatology Life Quality Index in Patients With Hidradenitis Suppurativa.
    Menon A; Gupta P; Suri RK; Thakare V; Dubey L; Patil S
    Cureus; 2023 Feb; 15(2):e35510. PubMed ID: 37007422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients.
    Rymaszewska JE; Krajewski PK; Szczęch J; Szepietowski JC
    Postepy Dermatol Alergol; 2023 Feb; 40(1):35-39. PubMed ID: 36909902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.